Stevenson JC - Search Results

1

Serum angiotensin-I-converting enzyme activity in women with cardiological syndrome X: relation to blood pressure and lipid and carbohydrate metabolic risk markers for coronary heart disease.

Proudler AJ, Crook D, Godsland IF, Collins P, Rosano GM, Stevenson JC. Proudler AJ, et al. Among authors: stevenson jc. J Clin Endocrinol Metab. 1995 Feb;80(2):696-9. doi: 10.1210/jcem.80.2.7852538. J Clin Endocrinol Metab. 1995. PMID: 7852538

2

Danazol induces resistance to both insulin and glucagon in young women.

Bruce R, Godsland I, Stevenson J, Devenport M, Borth F, Crook D, Ghatei M, Whitehead M, Wynn V. Bruce R, et al. Clin Sci (Lond). 1992 Feb;82(2):211-7. doi: 10.1042/cs0820211. Clin Sci (Lond). 1992. PMID: 1311660 Clinical Trial.

3

Ageing and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women.

Proudler AJ, Felton CV, Stevenson JC. Proudler AJ, et al. Among authors: stevenson jc. Clin Sci (Lond). 1992 Oct;83(4):489-94. doi: 10.1042/cs0830489. Clin Sci (Lond). 1992. PMID: 1330412

4

Insulin resistance and cigarette smoking.

Godsland IF, Wynn V, Walton C, Stevenson JC. Godsland IF, et al. Among authors: stevenson jc. Lancet. 1992 Jun 27;339(8809):1619-20. doi: 10.1016/0140-6736(92)91890-k. Lancet. 1992. PMID: 1351597 No abstract available.

5

Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid.

Crook D, Sidhu M, Seed M, O'Donnell M, Stevenson JC. Crook D, et al. Among authors: stevenson jc. Atherosclerosis. 1992 Jan;92(1):41-7. doi: 10.1016/0021-9150(92)90008-5. Atherosclerosis. 1992. PMID: 1533522

6

Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins.

Crook D, Cust MP, Gangar KF, Worthington M, Hillard TC, Stevenson JC, Whitehead MI, Wynn V. Crook D, et al. Among authors: stevenson jc. Am J Obstet Gynecol. 1992 Mar;166(3):950-5. doi: 10.1016/0002-9378(92)91370-p. Am J Obstet Gynecol. 1992. PMID: 1550171 Clinical Trial.

7

Hormone replacement therapy: risks and benefits.

Whitcroft SI, Stevenson JC. Whitcroft SI, et al. Among authors: stevenson jc. Clin Endocrinol (Oxf). 1992 Jan;36(1):15-20. doi: 10.1111/j.1365-2265.1992.tb02896.x. Clin Endocrinol (Oxf). 1992. PMID: 1559294 Review. No abstract available.

8

Progestogens, lipid metabolism and hormone replacement therapy.

Crook D, Stevenson JC. Crook D, et al. Among authors: stevenson jc. Br J Obstet Gynaecol. 1991 Aug;98(8):749-50. doi: 10.1111/j.1471-0528.1991.tb13477.x. Br J Obstet Gynaecol. 1991. PMID: 1911580 No abstract available.

9

Transdermal administration of oestrogen/progestagen hormone replacement therapy.

Whitehead MI, Fraser D, Schenkel L, Crook D, Stevenson JC. Whitehead MI, et al. Among authors: stevenson jc. Lancet. 1990 Feb 10;335(8685):310-2. doi: 10.1016/0140-6736(90)90605-5. Lancet. 1990. PMID: 1967769 Clinical Trial.

10

Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors.

Crook D, Gardner R, Worthington M, Nolan J, Stevenson JC, Shaw RW. Crook D, et al. Among authors: stevenson jc. Horm Res. 1989;32 Suppl 1:157-60. doi: 10.1159/000181334. Horm Res. 1989. PMID: 2533147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

376 results

Search Page